Cite
HARVARD Citation
D'Haens, G. et al. (2022). Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Lancet. 399 (10340), pp. 2015-2030. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
D'Haens, G. et al. (2022). Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Lancet. 399 (10340), pp. 2015-2030. [Online].